Is Parkinson's disease-related mortality declining?

被引：6
|
作者：
Haberfeld, E. [1 ,2 ]
Louis, E. D. [1 ,2 ,3 ,4 ]
机构：
[1] Columbia Univ, Coll Phys & Surg, GH Sergievsky Ctr, New York, NY 10032 USA
[2] Columbia Univ, Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA
[3] Columbia Univ, Coll Phys & Surg, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10032 USA
[4] Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY 10032 USA
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2009年 / 16卷 / 09期
关键词：
D O I：
10.1111/j.1468-1331.2009.02711.x
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：964 / 965
页数：2
相关论文
共 50 条
  • [41] Mortality in Patients with Parkinson's Disease-Related Psychosis Treated with Pimavanserin Compared with Other Atypical Antipsychotics: A Cohort Study
    Layton, J. Bradley
    Forns, Joan
    McQuay, Lisa J.
    Danysh, Heather E.
    Dempsey, Colleen
    Anthony, Mary S.
    Turner, Mary Ellen
    DRUG SAFETY, 2023, 46 (02) : 195 - 208
  • [42] Evolution and Predictive Role of Plasma Alzheimer's Disease-related Pathological Biomarkers in Parkinson's Disease
    Lin, Junyu
    Ou, Ruwei
    Li, Chunyu
    Hou, Yanbing
    Zhang, Lingyu
    Wei, Qianqian
    Liu, Kuncheng
    Jiang, Qirui
    Yang, Tianmi
    Xiao, Yi
    Pang, Dejiang
    Zhao, Bi
    Chen, Xueping
    Yang, Jing
    Shang, Huifang
    JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 2023, 78 (12): : 2203 - 2213
  • [43] Interaction Map and Selection of microRNA Targets in Parkinson's Disease-Related Genes
    Santosh, Shinde P.
    Arora, Neelima
    Sarma, Pranjal
    Pal-Bhadra, Manika
    Bhadra, Utpal
    JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY, 2009,
  • [44] Pimavanserin for Psychosis in Parkinson’s Disease-Related Disorders: A Retrospective Chart Review
    Jessie Sellers
    R. Ryan Darby
    Alma Farooque
    Daniel O. Claassen
    Drugs & Aging, 2019, 36 : 647 - 653
  • [45] Locus coeruleus volume is reduced in Parkinson's Disease-related orthostatic hypotension
    Beach, P.
    Kurra, N.
    Hwang, K.
    Langley, J.
    Hu, X.
    Huddleston, D.
    MOVEMENT DISORDERS, 2021, 36 : S408 - S409
  • [46] Pimavanserin for Psychosis in Parkinson's Disease-Related Disorders: A Retrospective Chart Review
    Sellers, Jessie
    Darby, R. Ryan
    Farooque, Alma
    Claassen, Daniel O.
    DRUGS & AGING, 2019, 36 (07) : 647 - 653
  • [47] Parkinson's disease-related fatigue: A case definition and recommendations for clinical research
    Kluger, Benzi M.
    Herlofson, Karen
    Chou, Kelvin L.
    Lou, Jau-Shin
    Goetz, Christopher G.
    Lang, Anthony E.
    Weintraub, Daniel
    Friedman, Joseph
    MOVEMENT DISORDERS, 2016, 31 (05) : 625 - 631
  • [48] Disease-related variables effect on depression and anxiety level in Parkinson's patients
    Uyar, T.
    Varlik, D. Sarikaya
    Ercan, A.
    Cenker, O. C.
    Dogan, I. Gungor
    MOVEMENT DISORDERS, 2016, 31 : S493 - S493
  • [49] Characterization of Parkinson's disease-related pathogenic TMEM230 mutants
    Nam, Daleum
    Kim, Hyejung
    Choi, Dong-Joo
    Bae, Yun-Hee
    Lee, Byoung Dae
    Son, Ilhong
    Seol, Wongi
    ANIMAL CELLS AND SYSTEMS, 2018, 22 (02) : 140 - 147
  • [50] Risky business? Crohns disease-related mortality
    Osterman, MT
    INFLAMMATORY BOWEL DISEASES, 2006, 12 (03) : 246 - 248
12345